Fingolimod use and annual expenditure (2017-2020)
Request for volume and expenditure of fingolimod for the last 3 years by community and hospital.
16 November 2020
Dear [name and contact details redacted]
REQUEST FOR INFORMATION
Thank you for your request dated 19 October 2020 under the Official Information Act 1982 (OIA) for information relating to fingolimod. You asked for:
- annual volume last 3 years of fingolimod split by community and hospital
- annual expenditure last 3 years fingolimod split by community and hospital.
Please find the information requested below. Data has been provided for the past 3 financial years (FYR) to the end of June 2020.
|
Community data |
|||
|
FYR |
Chemical name |
Volume (caps) |
Gross cost (NZD) |
|
2017/18 |
Fingolimod |
142,835 |
13,518,312.95 |
|
2018/19 |
Fingolimod |
142,201 |
11,743,423.23 |
|
2019/20 |
Fingolimod |
151,737 |
11,922,192.71 |
|
Hospital data |
|||
|
FYR |
Chemical name |
Volume (caps) |
Gross cost (NZD) |
|
2017/18 |
Fingolimod |
224 |
21,451.75 |
|
2018/19 |
Fingolimod |
196 |
15,149.17 |
|
2019/20 |
Fingolimod |
107 |
8,638.14 |
A confidential rebate applies to fingolimod, so the actual net cost is lower than the gross cost shown in the table.
We trust that this information answers your queries. We are making our information more freely available, so we will now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.
Yours sincerely
Rachel Read
Manager, Policy and Government Services